ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

331
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
bullishLG Chem Ltd
04 Sep 2020 12:20

Korea-New Deal Index: Constituents, Weights, & Market Reaction

The Korean government unveiled the specifics of the Korean version of the New Deal initiative.

Logo
330 Views
Share
bullishCelltrion Inc
04 Sep 2020 04:55

How Might a Celltrion Merger Look?

The key seems what happens to the value of Celltrion Holdings and in fact, the merger might not include Celltrion Inc.   The consensus belief is...

Logo
337 Views
Share
bullishWuxi Biologics
01 Sep 2020 18:25

Wuxi Biologics Placement - Another One Before Lock-Up, but Just in Time for the Index Inclusion

Wuxi Biologics (Cayman) Inc (2269 HK) has seen a total of ten placements since listing in Jun 2017. We've covered all of the deals. Given that the...

Logo
423 Views
Share
29 Aug 2020 07:18

Asia Short Interest Weekly: Sunny Optical, Alibaba, Anta, KDDI, M3, Square Enix, Samsung, Largan

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
277 Views
Share
17 Aug 2020 09:14

Who Will Buy SamE Stake Potentially Sold by Samsung Life? Samsung C&T or SamE?

Samsung C&T is one of the most likely candidates to purchase additional stakes in Samsung Electronics. One of the strategies that Samsung...

Logo
257 Views
Share
x